NO931585L - Radioaktiv merking - Google Patents

Radioaktiv merking

Info

Publication number
NO931585L
NO931585L NO93931585A NO931585A NO931585L NO 931585 L NO931585 L NO 931585L NO 93931585 A NO93931585 A NO 93931585A NO 931585 A NO931585 A NO 931585A NO 931585 L NO931585 L NO 931585L
Authority
NO
Norway
Prior art keywords
hydroxyalkyl
alkylcarboxy
tetra
hydroxy
alkyl
Prior art date
Application number
NO93931585A
Other languages
English (en)
Other versions
NO931585D0 (no
NO306407B1 (no
Inventor
Gary James Bridger
Pedro Emilio Hernandez
Iii John David Higgins
Scott Kenneth Larsen
Original Assignee
Johnson Matthey Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson Matthey Plc filed Critical Johnson Matthey Plc
Publication of NO931585D0 publication Critical patent/NO931585D0/no
Publication of NO931585L publication Critical patent/NO931585L/no
Publication of NO306407B1 publication Critical patent/NO306407B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00Compounds containing elements of Groups 7 or 17 of the Periodic System
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00Compounds containing elements of Groups 7 or 17 of the Periodic System
    • C07F13/005Compounds without a metal-carbon linkage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0474Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0476Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from monodendate ligands, e.g. sestamibi
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0474Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/12Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of acyclic carbon skeletons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Confectionery (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Road Signs Or Road Markings (AREA)
  • Casings For Electric Apparatus (AREA)
  • Hydrogenated Pyridines (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO931585A 1992-05-02 1993-04-30 Kompleks, fremgangsmaate for dannelse derav, radioaktivt merket makromolekyl og anvendelse av ligand med formel L NO306407B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929209641A GB9209641D0 (en) 1992-05-02 1992-05-02 Improvements in radiolabelling

Publications (3)

Publication Number Publication Date
NO931585D0 NO931585D0 (no) 1993-04-30
NO931585L true NO931585L (no) 1993-11-03
NO306407B1 NO306407B1 (no) 1999-11-01

Family

ID=10714995

Family Applications (1)

Application Number Title Priority Date Filing Date
NO931585A NO306407B1 (no) 1992-05-02 1993-04-30 Kompleks, fremgangsmaate for dannelse derav, radioaktivt merket makromolekyl og anvendelse av ligand med formel L

Country Status (19)

Country Link
US (1) US5350837A (no)
EP (1) EP0569132B1 (no)
JP (1) JP3271259B2 (no)
KR (1) KR100293777B1 (no)
AT (1) ATE190063T1 (no)
AU (1) AU663581B2 (no)
CA (1) CA2094380C (no)
DE (1) DE69327914T2 (no)
DK (1) DK0569132T3 (no)
ES (1) ES2143489T3 (no)
FI (1) FI931968A (no)
GB (1) GB9209641D0 (no)
GR (1) GR3033379T3 (no)
HK (1) HK1013828A1 (no)
NO (1) NO306407B1 (no)
NZ (1) NZ247445A (no)
PT (1) PT569132E (no)
TW (1) TW227564B (no)
ZA (1) ZA932844B (no)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5879657A (en) * 1993-03-30 1999-03-09 The Dupont Merck Pharmaceutical Company Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
US5744120A (en) * 1993-03-30 1998-04-28 The Dupont Merick Pharmaceutical Company Ternary radiopharmaceutical complexes
US5480970A (en) * 1993-12-22 1996-01-02 Resolution Pharmaceuticals Metal chelators
US5569745A (en) * 1994-02-25 1996-10-29 Resolution Pharmaceuticals Inc. Peptide-Chelator conjugates
ZA955642B (en) * 1994-07-07 1997-05-06 Ortho Pharma Corp Lyophilized imaging agent formulation
US5662885A (en) * 1994-07-22 1997-09-02 Resolution Pharmaceuticals Inc. Peptide derived radionuclide chelators
US5942210A (en) * 1994-11-15 1999-08-24 Cytogen Corporation Methods for lyoprotecting a macromolecule using tricine
US5879659A (en) * 1996-03-13 1999-03-09 Dupont Pharmaceuticals Company Ternary radiopharmaceutical complexes
ATE244023T1 (de) * 1996-03-13 2003-07-15 Bristol Myers Squibb Pharma Co Ternäre radiopharmazeutische komplexe
US20030124053A1 (en) * 1996-10-07 2003-07-03 Barrett John Andrew Radiopharmaceuticals for imaging infection and inflammation
US6416733B1 (en) 1996-10-07 2002-07-09 Bristol-Myers Squibb Pharma Company Radiopharmaceuticals for imaging infection and inflammation
US6403054B1 (en) 1997-05-28 2002-06-11 Bristol-Myers Squibb Pharma Company Ternary ligand complexes useful as radiopharmaceuticals
US6524553B2 (en) 1998-03-31 2003-02-25 Bristol-Myers Squibb Pharma Company Quinolone vitronectin receptor antagonist pharmaceuticals
US6548663B1 (en) 1998-03-31 2003-04-15 Bristol-Myers Squibb Pharma Company Benzodiazepine vitronectin receptor antagonist pharmaceuticals
US6537520B1 (en) 1998-03-31 2003-03-25 Bristol-Myers Squibb Pharma Company Pharmaceuticals for the imaging of angiogenic disorders
WO1999051628A1 (en) 1998-04-03 1999-10-14 Du Pont Pharmaceuticals Company Radiopharmaceuticals for imaging infection and inflammation and for imaging and treatment of cancer
US6511649B1 (en) * 1998-12-18 2003-01-28 Thomas D. Harris Vitronectin receptor antagonist pharmaceuticals
US6569402B1 (en) 1998-12-18 2003-05-27 Bristol-Myers Squibb Pharma Company Vitronectin receptor antagonist pharmaceuticals
US6794518B1 (en) * 1998-12-18 2004-09-21 Bristol-Myers Squibb Pharma Company Vitronectin receptor antagonist pharmaceuticals
EP1140204A2 (en) 1998-12-18 2001-10-10 Du Pont Pharmaceuticals Company Vitronectin receptor antagonist pharmaceuticals
CA2349333A1 (en) 1998-12-18 2000-06-22 Du Pont Pharmaceuticals Company Vitronectin receptor antagonist pharmaceuticals
US6346547B1 (en) * 1999-02-08 2002-02-12 Checkpoint, Genetics, Inc. N-substituted amino acids, antioxidant pharmaceutical compositions containing n-substituted amino acids and methods for preventing cardiovascular diseases and/or preventing and/or treating antioxidant responsive diseases therewith
US6808698B1 (en) 1999-03-26 2004-10-26 Bristol-Myers Squibb Pharma Company Method for localization of blood clots
US6534038B2 (en) 2000-04-07 2003-03-18 Bristol-Myers Squibb Pharma Company Ternary ligand complexes useful as radiopharmaceuticals
JP2004512382A (ja) * 2000-11-03 2004-04-22 ブリストル−マイヤーズ・スクイブ・ファーマ・カンパニー 心臓灌流および心臓炎症の2核種同時イメージング
US6517814B2 (en) 2001-01-09 2003-02-11 Bristol-Myers Squibb Pharma Company Macrocyclic chelants useful for metallopharmaceuticals
US6776977B2 (en) 2001-01-09 2004-08-17 Bristol-Myers Squibb Pharma Company Polypodal chelants for metallopharmaceuticals
US6838074B2 (en) 2001-08-08 2005-01-04 Bristol-Myers Squibb Company Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent
AU2002331042B2 (en) * 2001-08-08 2007-10-25 Bristol-Myers Squibb Pharma Company Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent
US7319149B2 (en) * 2003-06-13 2008-01-15 Bristol-Myers Squibb Pharma Company Chelants and macrocyclic metal complex radiopharmaceuticals thereof
US7317104B2 (en) 2003-06-13 2008-01-08 Bristol-Myers Squibb Pharma Company Chelants and macrocyclic metal complex radiopharmaceuticals thereof
US20050106100A1 (en) * 2003-09-03 2005-05-19 Harris Thomas D. Compounds containing matrix metalloproteinase substrates and methods of their use
KR20080022588A (ko) * 2005-06-30 2008-03-11 브리스톨-마이어스 스퀴브 파마 컴퍼니 영상화제로서의 히드라지드 컨쥬게이트
US8334402B2 (en) 2008-04-17 2012-12-18 Thomas Daly Biological buffers with wide buffering ranges
US9447310B2 (en) 2008-04-17 2016-09-20 Thomas P. Daly Biological buffers with wide buffering ranges
US7635791B2 (en) * 2008-04-17 2009-12-22 Tpat Ip Llc Biological buffers with wide buffering ranges
US20170313920A1 (en) 2010-10-06 2017-11-02 Thomas P. Daly Biological Buffers with Wide Buffering Ranges
US9090638B2 (en) 2008-04-17 2015-07-28 Thomas Daly Biological buffers with wide buffering ranges
US8519141B2 (en) 2008-04-17 2013-08-27 Thomas Daly Biological buffers with wide buffering ranges
US7939659B2 (en) * 2008-04-17 2011-05-10 Thomas Daly Biological buffers with wide buffering ranges
US8822728B2 (en) 2008-04-17 2014-09-02 Thomas Daly Biological buffers with wide buffering ranges
US8034951B2 (en) * 2008-04-17 2011-10-11 Thomas Daly Biological buffers with wide buffering ranges
US9475754B2 (en) 2011-10-06 2016-10-25 Thomas P. Daly Biological buffers with wide buffering ranges

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD118526A5 (no) * 1974-04-30 1976-03-12
US4017596A (en) * 1975-03-03 1977-04-12 Research Corporation Radiopharmaceutical chelates and method of external imaging
US4425280A (en) * 1981-03-30 1984-01-10 Ferro Corporation Metal amino acids
US4772724A (en) * 1986-12-02 1988-09-20 Warner-Lambert Canada Inc. Essentially pure acid hydroxyl ligand aluminum complexes and their preparation
EP0466200B1 (en) * 1987-07-16 1996-04-24 Nycomed Imaging As Aminocarboxylic acids and derivatives thereof
IL93432A (en) * 1989-02-24 1994-02-27 Johnson Mathey Inc Hydrazines and hydrazides, their conjugates with macromolecules, and such conjugates labeled with metallic ions

Also Published As

Publication number Publication date
JPH0665169A (ja) 1994-03-08
DE69327914D1 (de) 2000-04-06
AU3717393A (en) 1993-11-04
JP3271259B2 (ja) 2002-04-02
GB9209641D0 (en) 1992-06-17
CA2094380A1 (en) 1993-11-03
US5350837A (en) 1994-09-27
PT569132E (pt) 2000-08-31
CA2094380C (en) 2002-02-12
AU663581B2 (en) 1995-10-12
HK1013828A1 (en) 1999-09-10
ES2143489T3 (es) 2000-05-16
ZA932844B (en) 1994-06-21
KR930023028A (ko) 1993-12-18
ATE190063T1 (de) 2000-03-15
FI931968A0 (fi) 1993-04-30
TW227564B (no) 1994-08-01
NO931585D0 (no) 1993-04-30
DK0569132T3 (da) 2000-07-31
NO306407B1 (no) 1999-11-01
EP0569132A1 (en) 1993-11-10
KR100293777B1 (ko) 2001-11-22
GR3033379T3 (en) 2000-09-29
DE69327914T2 (de) 2000-06-29
NZ247445A (en) 1995-07-26
EP0569132B1 (en) 2000-03-01
FI931968A (fi) 1993-11-03

Similar Documents

Publication Publication Date Title
NO931585D0 (no) Radioaktiv merking
NO923912D0 (no) Lukkeanordning ved avtagbar tetning
BE888948A (fr) Fermeture d'activiation pour une fiole
BR8307174A (pt) Fecho corredico de vedacao
FR2526114B1 (fr) Unite d'etancheite et de guidage pour pistons en general
ES266257Y (es) "cursor para cierres de cremallera".
DE69417970T2 (de) Quelle für schnelle Atomstrahlen
DE69104794D1 (de) "BOP"-Dichtung mit verbesserten Metalleinsätzen.
FR2683491B1 (fr) Convertisseur d'energie pour ceinture de securite.
ES264189Y (es) "disposicion de cierre de cremallera".
FR2519100B1 (fr) Dispositif d'attache specialement destine aux toiles
FR2474872B1 (fr) Dispositif d'attache pour ceintures de securite
IT8367064A0 (it) Dispositivo di chiusura di sicurezza a scorrimento per sacchi di corrispondenza e simili
FR2536660B1 (fr) Fermeture de sangle pour une ceinture de securite
FR2692987B1 (fr) Dispositif de controle de l'etancheite de recipients fermes par un opercule.
FR2539201B1 (fr) Dispositif d'etancheite pour carter en deux parties longitudinales
ATA154890A (de) Verschluss für behälter
BR8304925A (pt) Arranjo para travar o dispositivo que desenrola o cinto de seguranca de um veiculo
FR2659720B1 (fr) Perfectionnement aux appareillages d'etanchement de canalisations enterrees.
AR227480A1 (es) Cierre para bolsa portadora de caudales
ES1012875Y (es) Cierre practicable para mamparas de bano.
DK131693D0 (da) Immunoassay for molekyler indeholdende alfa 1-kaeden af det n-terminale propeptid i humant procollagen type i
ES265190Y (es) "cierre de seguridad para bolsas y sobres".
IT223982Z2 (it) Borsa per documenti o simili
ES1014126Y (es) "dispositivo colocador-accionador de sacos con valvula"

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees